Literature DB >> 13607265

Results of a clinical trial of G-28315, a sulfoxide analog of phenylbutazone, as a uricosuric agent in gouty subjects.

T F YU, J J BURNS, A B GUTMAN.   

Abstract

Entities:  

Keywords:  GOUT/therapy; PHENYLBUTAZONE/related compounds

Mesh：

Substances：

Year:  1958        PMID： 13607265     DOI： 10.1002/art.1780010606

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN： 0004-3591


× No keyword cloud information.
  7 in total

1.  Study of the paradoxical effects of salicylate in low, intermediate and high dosage on the renal mechanisms for excretion of urate in man.

Authors:  T F YU; A B GUTMAN
Journal:  J Clin Invest       Date:  1959-08       Impact factor: 14.808

2.  MUTUAL SUPPRESSION OF THE URICOSURIC EFFECTS OF SULFINPYRAZONE AND SALICYLATE: A STUDY IN INTERACTIONS BETWEEN DRUGS.

Authors:  T F YUE; P G DAYTON; A B GUTMAN
Journal:  J Clin Invest       Date:  1963-08       Impact factor: 14.808

3.  Sulphinpyrazone in the treatment of arthritis associated with hyperuricaemia.

Authors:  E N GLICK
Journal:  Proc R Soc Med       Date:  1961-05

4.  NEW DRUGS.

Authors: 
Journal:  Can Med Assoc J       Date:  1959-04-01       Impact factor: 8.262

Review 5.  Antirheumatic drugs: clinical pharmacology and therapeutic use.

Authors:  G L Craig; W W Buchanan
Journal:  Drugs       Date:  1980-12       Impact factor: 9.546

Review 6.  Pharmacology of uricosuric drugs.

Authors:  I Kippen; M W Whitehouse; J R Klinenberg
Journal:  Ann Rheum Dis       Date:  1974-07       Impact factor: 19.103

7.  Comparison of the uricosuric effect of sulfinpyrazone (anturan) and zoxazolamine (flexin).

Authors:  D B MONTGOMERY; M A OGRYZLO
Journal:  Can Med Assoc J       Date:  1960-10-22       Impact factor: 8.262
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.